INKT — MINK THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | -1276.1% | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.61 | — | -0.59 | -0.63 | 2 | −1 |
| Mar 2027 | -0.61 | — | -0.61 | -0.61 | 1 | — |
| Jun 2027 | -0.61 | — | -0.61 | -0.61 | 1 | — |
| Sep 2027 | -0.56 | — | -0.56 | -0.56 | 1 | — |
| Dec 2027 | -0.62 | — | -0.62 | -0.62 | 1 | — |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -2.31 | — | -2.29 | -2.32 | 2 | +1−1 |
| Dec 2027 | -1.52 | — | -0.64 | -2.40 | 2 | +2 |
| Dec 2028 | -1.45 | — | -0.64 | -2.26 | 2 | +2 |
| Dec 2029 | -4.03 | — | -4.03 | -4.03 | 1 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 26 SEC-registered investment managers reported holding INKT (MINK THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $2.44M across 194.63K shares. That is -3.7% by share count (-7.40K shares) versus the previous quarter, while reported value moved +3.4%. Ownership is concentrated: the five largest holders account for 82.7% of reported value and the top ten for 98.9%.
Compared with the prior quarter, 1 opened new positions, 5 added to existing stakes, 5 trimmed, 6 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of MINK THERAPEUTICS INC (INKT) include VANGUARD CAPITAL MANAGEMENT LLC, Vanguard Group, DnB Asset Management AS, ranked by reported 13F value among the 73 institutional holders on this page.
INKT is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 26 | 194.63K | $2.44M | -3.7% |
| Q2 2026 | 31 | 233.81K | $2.73M | +3.4% |
| Q1 2026 | 24 | 139.83K | $1.47M | +13.3% |
| Q4 2025 | 25 | 140.53K | $1.57M | +33.3% |
| Q3 2025 | 19 | 104.31K | $1.46M | +25.2% |
| Q2 2025 | 20 | 141.28K | $463.25K | -1.0% |
| Q1 2025 | 19 | 450.10K | $702.73K | -54.8% |
| Q4 2024 | 25 | 1.20M | $694.65K | -0.8% |
Over the 8 quarters shown, institutional share counts decreased 84% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (-54.8%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 68.45K | $859.07K | 0.00% | Hold | |
| 43.96K | $551.70K | 0.00% | Reduce | |
| 18.76K | $235.46K | 0.00% | Add | |
| 16.67K | $209.17K | 0.03% | Hold | |
| 13.16K | $165.21K | 0.00% | Add | |
| 13.07K | $164.08K | 0.00% | Reduce | |
| 13.00K | $163.15K | 0.01% | Hold | |
| 2.00K | $25.10K | 0.00% | Hold | |
| 2.00K | $25.04K | 0.00% | Hold | |
| 1.46K | $18.35K | 0.00% | Reduce | |
| 750 | $9.41K | 0.00% | Add | |
| 500 | $6.28K | 0.00% | Reduce | |
| 303 | $3.80K | 0.00% | Reduce | |
| 118 | $1.48K | 0.00% | Add | |
| 117 | $1.43K | 0.00% | Hold | |
| 119 | $1.00K | 0.00% | Hold | |
| 72 | $1.00K | 0.00% | New | |
| 26 | $326 | 0.00% | Add | |
| 18 | $226 | 0.00% | Hold | |
| 18 | $226 | 0.00% | Hold | |
| 16 | $201 | 0.00% | Hold | |
| 14 | $176 | 0.00% | Hold | |
| 13 | $163 | 0.00% | Hold | |
| 9 | $110 | 0.00% | Hold | |
| 4 | $50 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 68.66K | $802.63K | 0.00% | Add | |
| 55.14K | $644.61K | 0.00% | New | |
| 16.67K | $194.84K | 0.03% | Hold | |
| 15.57K | $182.08K | 0.00% | New | |
| 15.57K | $182.08K | 0.00% | Reduce | |
| 15.44K | $180.49K | 0.00% | New | |
| 13.38K | $156.44K | 0.00% | Add | |
| 13.00K | $151.97K | 0.01% | Hold | |
| 8.29K | $96.88K | 0.00% | Hold | |
| 4.88K | $57.11K | 0.00% | Reduce | |
| 2.00K | $23.38K | 0.00% | Hold | |
| 2.00K | $23.32K | 0.00% | New | |
| 1.00K | $11.69K | 0.01% | Hold | |
| 812 | $9.49K | 0.01% | New | |
| 500 | $5.84K | 0.00% | New | |
| 422 | $4.93K | 0.00% | Add | |
| 117 | $1.37K | 0.00% | Add | |
| 113 | $1.32K | 0.00% | Add | |
| 119 | $1.00K | 0.00% | Hold | |
| 24 | $281 | 0.00% | New | |
| 18 | $210 | 0.00% | Add | |
| 18 | $210 | 0.00% | Hold | |
| 16 | $187 | 0.00% | Hold | |
| 14 | $164 | 0.00% | Hold | |
| 13 | $152 | 0.00% | Reduce |
Q1 2026 — 24 funds
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 67.65K | $754.31K | 0.00% | Add | |
| 16.67K | $185.84K | 0.03% | Hold | |
| 14.25K | $158.88K | 0.00% | Add | |
| 13.00K | $144.95K | 0.01% | Hold | |
| 10.40K | $115.96K | 0.00% | Reduce | |
| 9.55K | $106.46K | 0.00% | Add | |
| 6.20K | $69.16K | 0.00% | Reduce | |
| 1.00K | $11.15K | 0.01% | New | |
| 568 | $6.33K | 0.00% | Hold | |
| 337 | $3.76K | 0.00% | New | |
| 295 | $3.29K | 0.00% | Reduce | |
| 160 | $1.78K | 0.00% | New | |
| 117 | $1.30K | 0.00% | Reduce | |
| 104 | $1.16K | 0.00% | Reduce | |
| 131 | $1.00K | 0.00% | Hold | |
| 20 | $223 | 0.00% | New | |
| 18 | $201 | 0.00% | Reduce | |
| 16 | $178 | 0.00% | Hold | |
| 16 | $178 | 0.00% | Hold | |
| 14 | $157 | 0.00% | Hold | |
| 9 | $100 | 0.00% | Hold | |
| 5 | $56 | 0.00% | New | |
| 4 | $45 | 0.00% | New | |
| 4 | $45 | 0.00% | Hold | |
| 1 | $11 | 0.00% | Hold |
Q3 2025 — 19 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 33.35K | $466.91K | 0.00% | Add | |
| 16.67K | $233.34K | 0.02% | Hold | |
| 14.60K | $204.40K | 0.00% | New | |
| 13.00K | $182.00K | 0.01% | New | |
| 12.81K | $179.32K | 0.00% | Add | |
| 6.30K | $88.17K | 0.00% | Reduce | |
| 5.65K | $79.07K | 0.00% | Add | |
| 926 | $12.96K | 0.00% | New | |
| 568 | $7.95K | 0.00% | Hold | |
| 131 | $2.00K | 0.00% | Hold | |
| 124 | $1.70K | 0.00% | Add | |
| 115 | $1.61K | 0.00% | Add | |
| 19 | $266 | 0.00% | Hold | |
| 16 | $224 | 0.00% | Reduce | |
| 16 | $224 | 0.00% | Hold | |
| 14 | $196 | 0.00% | Hold | |
| 9 | $126 | 0.00% | Reduce | |
| 4 | $59 | 0.00% | Hold | |
| 1 | $14 | 0.00% | Hold |
Q2 2025 — 20 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 23.74K | $177.60K | 0.00% | Hold | |
| 16.67K | $123.13K | 0.01% | Hold | |
| 11.49K | $85.98K | 0.00% | Add | |
| 7.42K | $54.82K | 0.00% | Reduce | |
| 849 | $6.27K | 0.00% | Hold | |
| 568 | $4.20K | 0.00% | Reduce | |
| 500 | $3.69K | 0.00% | New | |
| 79.36K | $2.50K | 0.00% | Hold | |
| 284 | $2.10K | 0.00% | Hold | |
| 131 | $1.00K | 0.00% | Add | |
| 120 | $883 | 0.00% | Reduce | |
| 32 | $236 | 0.00% | New | |
| 26 | $192 | 0.00% | Add | |
| 22 | $163 | 0.00% | Reduce | |
| 19 | $140 | 0.00% | Add | |
| 16 | $118 | 0.00% | Hold | |
| 14 | $104 | 0.00% | Hold | |
| 12 | $89 | 0.00% | Reduce | |
| 4 | $30 | 0.00% | New | |
| 1 | $7 | 0.00% | Hold |
New Positions (Q3 2026)
- ROYAL BANK OF CANADA 72 sh · $1.00K
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 15.57K sh · $182.08K
- Citadel Advisors sold 15.44K sh · $180.49K
- Big Sioux Wealth Management sold 812 sh · $9.49K
- BARCLAYS PLC sold 24 sh · $281
- LifeSteps Financial, Inc. sold 2 sh · $23
- BFC Planning, Inc. sold 2 sh · $23
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 68.45K | 68.66K | 59.36K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| DnB Asset Management AS | 43.96K | 55.14K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 18.76K | 15.57K | 17.34K | 14.25K | 12.81K | 11.49K | 11.25K | 96.11K | 97.98K | 96.35K | 88.86K | 90.16K | 90.16K | — | — | 25.30K | — | — |
| Longbow Finance SA | 16.67K | 16.67K | 16.67K | 16.67K | 16.67K | 16.67K | 16.67K | 166.67K | 166.67K | 166.67K | 166.67K | 166.67K | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 13.16K | 8.29K | 8.29K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 13.07K | 13.38K | 6.20K | 6.20K | 6.30K | 7.42K | 8.78K | 88.28K | 88.13K | — | — | — | — | — | — | — | — | — |
| BOLTON SECURITIES CORPORATION | 13.00K | 13.00K | 13.00K | 13.00K | 13.00K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Steward Partners Investment Advisory, LLC | 2.00K | 2.00K | 2.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| US BANCORP \DE\ | 2.00K | 2.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 1.46K | 4.88K | 15.20K | 9.55K | 5.65K | 284 | 284 | 2.85K | 6.21K | 3.22K | 3.23K | 5.04K | 3.55K | — | — | — | — | — |
| Federation des caisses Desjardins du Quebec | 750 | 500 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Paladin Partners, LLC | 500 | 1.00K | 1.00K | 1.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 303 | 422 | 156 | 295 | 926 | — | 172 | 5.40K | 4.03K | 8.95K | 11.06K | 10.94K | 7.70K | — | — | — | — | — |
| Morgan Stanley | 118 | 113 | 104 | 104 | 115 | 22 | 24 | 334 | 336 | 383 | 600 | 4.49K | 8.10K | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | 117 | 117 | 1 | 117 | 124 | 120 | 238 | 1.32K | 1.43K | 1.43K | 920 | 292 | 402 | — | — | — | — | — |
| Covestor Ltd | 119 | 119 | 119 | 131 | 131 | 131 | 104 | 1.05K | 1.05K | 1.05K | 1.05K | 1.07K | 1.08K | — | — | — | — | — |
| ROYAL BANK OF CANADA | 72 | — | — | — | — | — | — | — | — | — | — | 651 | 649 | — | — | — | — | — |
| Wells Fargo & Co | 26 | 2 | — | 20 | — | 849 | 848 | 10.08K | 10.53K | 10.86K | 11.02K | 11.53K | 12.12K | 27.42K | 33 | 32 | 445 | 1.21K |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 18 | 18 | 18 | 18 | 19 | 19 | 18 | 190 | 190 | 190 | 185 | 185 | 185 | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 18 | 18 | 10 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold INKT?
As of 2026-Q3, 26 institutional funds reported holding INKT (MINK THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $2.44M.
How many shares of INKT do institutions own?
13F filers reported 194.63K shares of INKT, worth $2.44M in aggregate at the end of 2026-Q3.
Is institutional ownership of INKT rising or falling?
Share counts moved -3.7% versus the prior quarter — distribution.
Who are the top institutional holders of INKT?
The largest 13F holders are VANGUARD CAPITAL MANAGEMENT LLC, Vanguard Group, DnB Asset Management AS, Geode Capital Management, Longbow Finance SA; the top 25 are ranked at the top of this page.
Who are the major shareholders of MINK THERAPEUTICS INC?
The major shareholders of MINK THERAPEUTICS INC (INKT) by reported 13F value are VANGUARD CAPITAL MANAGEMENT LLC, Vanguard Group, DnB Asset Management AS, Geode Capital Management, Longbow Finance SA, among 73 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.